Wilmot Team Science Pilot Program
The Wilmot Cancer Institute provides team science pilot funding to researchers at the University of Rochester whose work focuses on cancer. Proposals must target competitive multiple principal investigator (MPI) R01 grant applications to the National Cancer Institute (NCI), and may involve basic, translational, clinical, or population science research. At least two PIs are required for each application; at least one PI must be a Wilmot member.
Particular emphasis is given to projects that:
- Develop inter-programmatic collaborations (that is, collaborations involving members of at least two Wilmot research programs)
- Already have proven feasability
- Are relevant to Wilmot catchment area priorities
- Align with the Wilmot strategic plan
Statements of Intent are due Oct. 16, 2023. Invited full applications are due Nov. 20, 2023. Projects are expected to start Jan. 2, 2024. Download the RFA.
Please contact Thom Fogg with questions.
Past Award Recipients
Elucidating the Role of GSH in Cancer-Associated Cachexia
PIs: Calvin Cole, Ph.D.; Isaac Harris, Ph.D.; David Linehan, M.D.; Joshua Munger, Ph.D.
BRAT1 May Recruit INTS11 RNA Cleavage Activity to Areas of DNA Damage to Impact Local Transcription Complexes
PIs: Brian Marples, Ph.D.; Eric Wagner, Ph.D.
The Role of Mesenchymal Stromal Cells and Aging in Myelodysplastic Syndromes
PIs: Laura Calvi, M.D.; Vera Gorbunova, Ph.D.; Clara Kielkopf, Ph.D.; Jane Liesveld, M.D.; Kah Poh Loh, M.D.
Dormancy versus Cell Death: Investigating a Novel Function of the Circadian Rhythm Gene Dec2 in Pancreatic Cancer Dormancy
PIs: Brian Altman, Ph.D.; Darren Carpizo, M.D., P.h.D.; Paula Vertino, Ph.D.